Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Rachel A. Burich
Escalating Weekly Doses of Cetuximab and Correlation With Skin Toxicity: A Phase I Study
Investigational New Drugs
Oncology
Pharmacology
Related publications
Pharmacokinetics of Cetuximab After Administration of Escalating Single Dosing and Weekly Fixed Dosing in Patients With Solid Tumors
Clinical Cancer Research
Cancer Research
Oncology
P1.01-91 a Phase I Study of Fixed Dose Vinorelbine and Escalating Doses of Ifosfamide in First-Line Advanced Non-Small Cell Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
273. Phase I Trial of Escalating Doses of SGT-53 Infusion in Combination With Docetaxel in Advanced Solid Tumor Patients
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
A Phase I Study of Weekly Topotecan in Combination With Pemetrexed in Patients With Advanced Malignancies
Oncologist
Cancer Research
Medicine
Oncology
A Phase I and Pharmacokinetic Study of Weekly Paclitaxel and Carboplatin in Patients With Metastatic Esophageal Cancer
Clinical Cancer Research
Cancer Research
Oncology
Phase I and Pharmacokinetic Study of Weekly Docetaxel, Cisplatin, and Daily Capecitabine in Patients With Advanced Solid Tumors
Clinical Cancer Research
Cancer Research
Oncology
Phase I Trial of Weekly Topotecan and Gemcitabine in Patients With Solid Tumors
American Journal of Clinical Oncology: Cancer Clinical Trials
Cancer Research
Oncology
Myeloablative I-131-Tositumomab With Escalating Doses of Fludarabine and Autologous Hematopoietic Transplantation for Adults Age ≥ 60 Years With B Cell Lymphoma
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
A Phase I Study of VB4–845 in Patients With Advanced, Recurrent Head and Neck Cancer on a Weekly Dosing Scheme
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
